Abstract:The present study describes the synthesis and biological evaluation of In-111(DOTA-3P-RGD(2)) (DOTA = 1,4,7,10-tetraazacyclo-dodecane-1,4,7,10-tetraacetic acid; 3P-RGD(2) = PEG(4)-E[PEG(4)-c(RGDfK)](2); PEG(4) = 15-amino-4,7,10,13-tetraoxapentadecanoic acid), In-111(DTPA-3P-RGD(2)) (DTPA = diethylenetriaminepentaacetic acid) and In-111(DTPA-Bn-3P-RGD(2)) (DTPA-Bn = 2-(p-thioureidobenzyl)-diethylenetriaminepentaacetic acid) as potential radiotracers for imaging tumor integrin alpha(v)beta(3) expression in athymic nude mice bearing U87MG glioma xenografts. The aim of the study is to assess the impact of the bifunctional chelator (BFC) (DOTA vs. DTPA or DTPA-Bn) on the biodistribution characteristics of the In-111-labeled 3P-RGD(2). IC50 values of DOTA-3P-RGD(2), DTPA-3P-RGD(2) and DTPA-Bn-3P-RGD(2) were determined to be 1.3 +/- A 0.2, 1.4 +/- A 0.3, 1.3 +/- A 0.3 nM, respectively, against I-125-c(RGDyK) bound to U87MG human glioma cells. Radiotracers were prepared by reacting (InCl3)-In-111 with the RGD peptide conjugates in NH4OAc buffer (100 mM, pH 5.5). For DOTA-3P-RGD(2), successful radiolabeling could be completed by heating the reaction mixture at 100A degrees C for 15-20 min. For DTPA-3P-RGD(2) and DTPA-Bn-3P-RGD(2), the radiolabeling was almost instantaneous at room temperature. The specific activity was similar to 50 mCi/mg (or similar to 100 mCi/mu mol) for In-111(DOTA-3P-RGD(2)) and similar to 200 mCi/mg (or similar to 400 mCi/mu mol) for In-111(DTPA-3P-RGD(2)). The results from biodistribution studies showed that all the three radiotracers have high tumor uptake and excellent tumor-to-background (T/B) ratios up to 4-h postinjection. After that time point, both In-111(DTPA-3P-RGD(2)) and In-111(DTPA-Bn-3P-RGD(2)) showed a much faster tumor washout and poorer T/B ratios than In-111(DOTA-3P-RGD(2)). The tumor uptake of In-111(DOTA-3P-RGD(2)) is integrin alpha(v)beta(3)- and RGD-specific. In-111(DOTA-3P-RGD(2)) is metabolically stable while only similar to 25% of In-111(DTPA-Bn-3P-RGD(2)) remains intact in the feces during 2-h period. On the basis of results from this study, it was concluded that In-111(DTPA-3P-RGD(2)) can be an effective integrin alpha(v)beta(3)-targeted radiotracer if the high-specific activity is required. However, DOTA remains to be the BFC of choice for the development of therapeutic lanthanide radiotracers.

Clinical Application of Radioimmunoimaging with (99)~m Tc-BDI-1 in the Diagnosis of Bladder Cancer

Radioimmunoimaging Diagnosis of Human Bladder Carcinoma.

Characteristics in Biodistribution and Metabolism of 131 I Labeled Immunotoxin Against Human Bladder Carcinoma in Tumor-Bearing Nude Mice

The Application Of Tc-99m Labeled Hematoporphyrin Derivative In The Radioimaging Diagnosis Of Bladder-Tumor

Evaluation of Tumor Vascular Targeting Agents Labelled with 131I in Imaging of Tumor

Novel Application of Cell Penetrating R11 Peptide for Diagnosis of Bladder Cancer

An Exploratory Study on 99Mtc-Rgd-bbn Peptide Scintimammography in the Assessment of Breast Malignant Lesions Compared to 99Mtc-3P4-rgd2.

Radiochemical Synthesis and Preliminary Evaluation of Anti‐bladder Cancer Monoclonal Antibody BDI‐1 Labeled with Rhenium‐188

A prospective study of Tc-99m MIBI in the differential diagnosis of pelvic masses in female patients

Targeted Diagnosis and Treatment of Superficial Bladder Cancer with Monoclonal Antibody BDI-1.

Amide Proton Transfer-Weighted MRI and Diffusion-Weighted Imaging in Bladder Cancer: A Complementary Tool to the VI-RADS.

Intravoxel Incoherent Motion Diffusion‐weighted Imaging in Assessing Bladder Cancer Invasiveness and Cell Proliferation

99Mtc-3P4-rgd2 Scintimammography in the Assessment of Breast Lesions: Comparative Study with 99Mtc-Mibi

Distribution and Safety After Intravesical Instillation of 5-[~(125)I]iodo-2'- Deoxyuridine in Tumor-bearing Rat

Impact Of Bifunctional Chelators On Biological Properties Of In-111-Labeled Cyclic Peptide Rgd Dimers

The thyroid cancer positive imaging with 99mTc-MIBI

99mTc-labeled iRGD for single-positron emission computed tomography imaging of triple-negative breast cancer

The Role of Diffusion-Weighted MR Imaging in Diagnosis of Bladder Cancer

Diagnostic Value by 99mTc-MIBI Semi-quantitative Imaging for Lung Neoplasms

Application of R2* and Apparent Diffusion Coefficient in Estimating Tumor Grade and T Category of Bladder Cancer.

Preliminary Clinical Study on Distinguishing Breast Tumor with 99tcm -HL91 Imaging